-
高通量测序建库
-
IVD PCR系列
-
PCR系列
-
qPCR系列
-
逆转录
-
克隆与突变
-
核酸合成与提取
-
核酸电泳系列
-
限制性内切酶
-
报告基因相关
-
细胞生物学
-
蛋白与免疫
-
重组蛋白
-
信号转导
-
常用试剂
-
基因编辑
-
实验室小仪器
-
实验耗材
产品规格:100μg
产品价格:¥ 3195.00
类别:细胞因子

说明书下载
-
Product Information
Product Name
Cat#
Size
Price(¥)
Recombinant Human Interferon-alpha2b (Human IFN-α2b)
91205ES60
100μg
3195.00
91205ES76
500μg
8745.00
Product Description
Interferons (IFN) are a family of cytokines with potent antiviral, antiproliferative and immunomodulatory properties, classified based on their binding specificity to cell surface receptors. There are more than a dozen closely related IFN alpha subtypes found in both the human and mouse genome, each sharing about 80% amino acid (aa) sequence homology. There are several variants of human IFNA2, IFNA2a, IFNA2b and IFNA2c, which only differ by a few point mutations. The extracellular domain (ECD) of mature human IFNA2b shares 59% aa sequence identity with mouse IFNA2. The type I IFNs bind to the interferon alpha receptor (IFNAR), which consists of two subunits: IFNAR1 (alpha -subunit) and IFNAR2 (beta -subunit). While individual IFN alpha subtypes are known to display unique efficacies to viral protection, nothing is known about functions unique to IFNA2 in human physiology. However, IFNA2 has become the representative type I IFN subtype used in basic research and numerous clinical applications. Since being first approved for treatment of hairy cell leukemia in 1986, IFNA2b has been approved for the treatment of several malignancies including AIDS-related Kaposi's sarcoma, malignant melanoma and chronic hepatitis B and C. More recently, human IFNA2b has been tested as a potential treatment for COVID-19.
Product Properties
Synonyms
IFN-alpha 2b protein
Accession
GeneID
Source
Yeast-derived Human IFN-α2a protein,Cys24-Glu188(K23R).
Molecular Weight
Approximately 19.2 kDa
AA Sequence
CDLPQTHSLG SRRTLMLLAQ MRKISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE
Tag
None
Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
> 98 % by SDS-PAGE and HPLC analyses.
Biological Activity
Fully biologically active when compared to standard. The specific activity determined by an anti-viral assay is no less than 1.6 × 108 IU/mg.
Endotoxin
< 0.1 EU per 1μg of the protein by the LAL method.
Formulation
Lyophilized from a 0.2 µm filtered solution in PBS, pH 7.4, with 0.02 % Tween-20.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.
Shipping and Storage
The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
1. Avoid repeated freeze-thaw cycle
2. For your safety and health, please wear lab coats and disposable gloves for operation.
3. For research use only.
HB220322